Clorox (NYSE:CLX – Get Rating) had its target price cut by Deutsche Bank Aktiengesellschaft from $152.00 to $147.00 in a research note published on Monday, The Fly reports.
CLX has been the topic of a number of other research reports. Raymond James upped their price target on shares of Clorox from $160.00 to $165.00 and gave the company an outperform rating in a research note on Friday, February 3rd. StockNews.com assumed coverage on shares of Clorox in a report on Thursday, March 16th. They issued a hold rating on the stock. Jefferies Financial Group upped their price objective on shares of Clorox from $140.00 to $145.00 and gave the company a hold rating in a report on Wednesday, February 1st. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $126.00 to $135.00 and gave the company an underweight rating in a report on Friday, January 13th. Finally, Wells Fargo & Company upped their price objective on shares of Clorox from $125.00 to $135.00 and gave the company an underweight rating in a report on Tuesday, January 3rd. Seven research analysts have rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of Hold and an average target price of $141.00.
Get Clorox alerts:Clorox Trading Down 0.0 %
NYSE CLX opened at $154.61 on Monday. The company has a quick ratio of 0.47, a current ratio of 0.86 and a debt-to-equity ratio of 5.04. The firm has a market cap of $19.10 billion, a PE ratio of 44.17, a price-to-earnings-growth ratio of 3.16 and a beta of 0.29. The company has a 50 day moving average price of $150.33 and a 200 day moving average price of $144.84. Clorox has a 52 week low of $120.50 and a 52 week high of $160.59.
Clorox (NYSE:CLX – Get Rating) last issued its quarterly earnings results on Thursday, February 2nd. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.66 by $0.32. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.66 billion. During the same quarter in the prior year, the business posted $0.66 EPS. Clorox's revenue for the quarter was up 1.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Clorox will post 4.23 EPS for the current fiscal year.
Clorox Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be issued a dividend of $1.18 per share. This represents a $4.72 annualized dividend and a yield of 3.05%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's payout ratio is 134.86%.
Hedge Funds Weigh In On Clorox
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. OLD Mission Capital LLC purchased a new position in Clorox during the fourth quarter valued at $29,000. Regal Investment Advisors LLC raised its position in shares of Clorox by 0.5% in the fourth quarter. Regal Investment Advisors LLC now owns 16,196 shares of the company's stock valued at $2,273,000 after buying an additional 84 shares during the last quarter. Voya Investment Management LLC raised its position in shares of Clorox by 1.0% in the fourth quarter. Voya Investment Management LLC now owns 73,600 shares of the company's stock valued at $10,328,000 after buying an additional 732 shares during the last quarter. Natixis raised its position in shares of Clorox by 1,416.6% in the fourth quarter. Natixis now owns 115,016 shares of the company's stock valued at $16,140,000 after buying an additional 107,432 shares during the last quarter. Finally, Kovack Advisors Inc. raised its position in shares of Clorox by 2.7% in the fourth quarter. Kovack Advisors Inc. now owns 3,002 shares of the company's stock valued at $421,000 after buying an additional 79 shares during the last quarter. 79.12% of the stock is owned by hedge funds and other institutional investors.
About Clorox
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Read More
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- KB Home Strong Results Lift Prices
- Chewy Stock Is Setting Up For Long-Term Profitable Growth
- Why Wall Street Loves These 3 Penny Stocks
- Carvana May Be Able To Reach Profitability This Year
- Low Volume Bunge Plunge Presents an Opportunity
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.